Search Results for keywords:"Merck Sharp

Sharp Clinical Services, LLC has submitted an application to register as an importer of certain controlled substances. The purpose of this registration is to import these substances for distribution and clinical trials, but not for commercial sales of finished products. The public can submit comments or objections electronically until March 28, 2025, and requests for a hearing on the application must be sent to the Drug Enforcement Administration by the same date.

The Department of the Treasury is asking for public comments on a form used to settle the estates of deceased individuals without formal administration. This form, known as FS Form 1050, allows creditors to request payment from Treasury Securities held in the deceased person's estate. The Bureau of the Fiscal Service is seeking input to ensure the collection of information remains effective and minimally burdensome under the requirements of the Paperwork Reduction Act of 1995. Comments are accepted until June 16, 2025.

Merck, Sharp & Dohme LLC submitted a proposal to the Foreign-Trade Zones Board to conduct production activities at its facility in Rahway, New Jersey. The request was reviewed according to the Board's regulations, and the public was invited to comment. On January 16, 2024, the Board decided no further review was needed, and the production activity was authorized under existing regulations. The notification was officially documented on January 16, 2025.

Merck, Sharp & Dohme LLC submitted a request to the Foreign-Trade Zones (FTZ) Board on October 18, 2024, to start production activities at its facility in Rahway, New Jersey, which is part of FTZ Subzone 49Y. The FTZ Board reviewed this request and announced in the Federal Register that public comments on the activity were welcome. On February 18, 2025, the FTZ Board decided that no further review was necessary and approved the proposed production activities, as long as they comply with FTZ regulations. This authorization was communicated to the applicant on the same day.

Merck, Sharp & Dohme LLC has submitted a proposal to the Foreign-Trade Zones Board for a production activity in their Rahway, New Jersey facility, which is part of Foreign-Trade Zone 49. The proposal outlines plans to manufacture various pharmaceutical products, including drugs for infectious and neurologic diseases, oncology, immunotherapy, and cardiovascular disease, using foreign materials. Some of these materials are subject to specific trade regulations depending on their country of origin. Public comments on the proposal are welcome until May 27, 2025, and those interested in more information can contact the Board or access documents on their website.

Merck, Sharp & Dohme LLC has informed the Foreign-Trade Zones (FTZ) Board about proposed production activities at their Rahway, New Jersey, facility, which is part of Subzone 49Y. The proposal includes producing drugs for metabolic and immunological disorders using specific foreign-sourced materials. Interested parties can submit their comments to the FTZ Board by February 24, 2025. More details and the notification can be accessed on the Board's website.

The U.S. Department of Commerce published a notice correcting a typographical error in a previous announcement about starting an investigation on ceramic abrasive grains from China. The error was related to the classification under the Harmonized Tariff Schedule, which needed correction in the appendix titled "Scope of the Investigation." The notice clarifies the correct subheadings and describes the characteristics and classifications of the ceramic abrasive grains under investigation. This update helps ensure the investigation proceeds with accurate information.

The U.S. Department of Commerce issued a correction to a previous notice regarding the less-than-fair-value investigation on ceramic abrasive grains from China. The error was a typographical mistake in the Harmonized Tariff Schedule of the United States (HTSUS) subheadings related to the investigation's scope. The corrected HTSUS subheadings are listed, and the notice emphasizes that the written description of the merchandise is crucial. The investigation focuses on ceramic abrasive grains that include specific compounds and are classified under particular HTSUS subheadings.

The DVD Copy Control Association (DVD CCA), under the National Cooperative Research and Production Act of 1993, has updated its membership, as disclosed in a notice to the Attorney General and the Federal Trade Commission. Panasonic Automotive Systems, located in Yokohama, Japan, has joined the association, while several companies, including Almedio Inc. and Sharp North Malaysia, have withdrawn. There are no other changes in the group's activity or membership, and the association plans to continue updating on any further changes. The last public notice regarding membership was published on June 21, 2024.

The National Institutes of Health announced upcoming meetings by the National Institute on Minority Health and Health Disparities that will be closed to the public to protect confidential information. These meetings, scheduled for March 16, 22, and 26, 2021, will focus on reviewing and evaluating grant applications related to conference grants and HIV prevention and care. The meetings will be held virtually, and each has a specified contact person for more information. These closed sessions aim to discuss sensitive and private information, ensuring personal privacy is maintained.